STAT+: Startup Altido Therapeutics pursues CAR-T for glioblastoma tumors
Nick Leschly, the CEO who became synonymous with the curative promise and complicated reality of gene therapy, is back with a new company. The startup, Altido Therapeutics, is trying to commercialize a